The HIF-1-mediated, tumor-specific upregulation of CAIX, its localization at the cell surface, its highly restricted expression in normal tissues, the association of CAIX upregulation with poor prognosis and its functional relevance to tumor biology all serve as key properties for its use as a therapeutic target. This evidence concerns the gene CA9 and neoplasm.